CADPS
Basic information
Region (hg38): 3:62398346-62875416
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CADPS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 20 | ||||
missense | 49 | 53 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 3 | 2 | 6 | ||
non coding | 2 | |||||
Total | 0 | 0 | 52 | 22 | 4 |
Variants in CADPS
This is a list of pathogenic ClinVar variants found in the CADPS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-62399451-G-T | CADPS-related disorder | Likely benign (Mar 21, 2024) | ||
3-62399465-C-T | CADPS-related disorder | Uncertain significance (Aug 15, 2024) | ||
3-62399469-T-G | not specified | Uncertain significance (Apr 19, 2024) | ||
3-62399594-G-A | CADPS-related disorder | Likely benign (Nov 04, 2019) | ||
3-62403098-G-C | CADPS-related disorder | Uncertain significance (Jun 06, 2024) | ||
3-62403100-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
3-62403141-C-T | CADPS-related disorder | Likely benign (Jun 25, 2019) | ||
3-62403156-GA-G | CADPS-related disorder | Uncertain significance (Sep 26, 2022) | ||
3-62403161-C-T | not specified | Uncertain significance (Jun 21, 2021) | ||
3-62403173-T-C | CADPS-related disorder | Likely benign (Apr 15, 2022) | ||
3-62403183-T-C | CADPS-related disorder | Uncertain significance (Mar 21, 2023) | ||
3-62438139-C-A | not specified | Uncertain significance (Dec 09, 2024) | ||
3-62438196-C-A | CADPS-related disorder • not specified | Uncertain significance (Mar 01, 2023) | ||
3-62445781-T-C | not specified | Uncertain significance (Oct 26, 2021) | ||
3-62465410-C-A | CADPS-related disorder | Uncertain significance (Apr 26, 2023) | ||
3-62465447-C-T | not specified | Uncertain significance (Jun 29, 2022) | ||
3-62466368-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
3-62466394-AT-A | Uncertain significance (May 01, 2017) | |||
3-62474166-T-C | CADPS-related disorder | Likely benign (Apr 09, 2019) | ||
3-62474171-A-C | CADPS-related disorder | Uncertain significance (Jan 03, 2024) | ||
3-62474264-C-T | not specified | Uncertain significance (Mar 04, 2024) | ||
3-62474310-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
3-62478322-T-C | not specified | Uncertain significance (Aug 28, 2024) | ||
3-62478354-C-T | not specified | Uncertain significance (Jun 26, 2024) | ||
3-62481726-G-A | not specified | Uncertain significance (Jun 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CADPS | protein_coding | protein_coding | ENST00000383710 | 30 | 477033 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000147 | 1.00 | 125718 | 0 | 29 | 125747 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.10 | 525 | 767 | 0.685 | 0.0000446 | 8911 |
Missense in Polyphen | 17 | 34.822 | 0.48819 | 321 | ||
Synonymous | -1.44 | 319 | 288 | 1.11 | 0.0000173 | 2521 |
Loss of Function | 5.64 | 24 | 77.6 | 0.309 | 0.00000432 | 862 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000154 | 0.000154 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000132 | 0.000132 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-binding protein involved in exocytosis of vesicles filled with neurotransmitters and neuropeptides. Probably acts upstream of fusion in the biogenesis or maintenance of mature secretory vesicles. Regulates catecholamine loading of DCVs. May specifically mediate the Ca(2+)-dependent exocytosis of large dense-core vesicles (DCVs) and other dense-core vesicles by acting as a PtdIns(4,5)P2-binding protein that acts at prefusion step following ATP-dependent priming and participates in DCVs-membrane fusion. However, it may also participate in small clear synaptic vesicles (SVs) exocytosis and it is unclear whether its function is related to Ca(2+) triggering (By similarity). {ECO:0000250}.;
Intolerance Scores
- loftool
- 0.384
- rvis_EVS
- -1.35
- rvis_percentile_EVS
- 4.63
Haploinsufficiency Scores
- pHI
- 0.465
- hipred
- Y
- hipred_score
- 0.658
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.373
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cadps
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- exocytosis;protein transport;synaptic vesicle exocytosis;dense core granule exocytosis
- Cellular component
- cytosol;cell junction;cytoplasmic vesicle membrane;presynapse
- Molecular function
- protein binding;lipid binding;protein kinase binding;metal ion binding